Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study

Aims The myocardium is considered to be an important target organ for parathyroid hormone and 1,25‐dihydroxyvitamin D, the active metabolite of vitamin D. Vitamin D inadequacy has also been linked to cardiovascular morbidity. We aimed to evaluate the relationship between serum 25‐hydroxyvitamin D [2...

Full description

Bibliographic Details
Published in:European Journal of Heart Failure
Main Authors: Kamycheva, Elena, Wilsgaard, Tom, Schirmer, Henrik, Jorde, Rolf
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2013
Subjects:
Online Access:http://dx.doi.org/10.1093/eurjhf/hfs210
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1093%2Feurjhf%2Fhfs210
https://onlinelibrary.wiley.com/doi/pdf/10.1093/eurjhf/hfs210
https://onlinelibrary.wiley.com/doi/full-xml/10.1093/eurjhf/hfs210
id crwiley:10.1093/eurjhf/hfs210
record_format openpolar
spelling crwiley:10.1093/eurjhf/hfs210 2024-06-02T08:15:20+00:00 Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study Kamycheva, Elena Wilsgaard, Tom Schirmer, Henrik Jorde, Rolf 2013 http://dx.doi.org/10.1093/eurjhf/hfs210 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1093%2Feurjhf%2Fhfs210 https://onlinelibrary.wiley.com/doi/pdf/10.1093/eurjhf/hfs210 https://onlinelibrary.wiley.com/doi/full-xml/10.1093/eurjhf/hfs210 en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor European Journal of Heart Failure volume 15, issue 5, page 490-495 ISSN 1388-9842 1879-0844 journal-article 2013 crwiley https://doi.org/10.1093/eurjhf/hfs210 2024-05-03T12:07:18Z Aims The myocardium is considered to be an important target organ for parathyroid hormone and 1,25‐dihydroxyvitamin D, the active metabolite of vitamin D. Vitamin D inadequacy has also been linked to cardiovascular morbidity. We aimed to evaluate the relationship between serum 25‐hydroxyvitamin D [25(OH)D] and LV systolic function in a general population. Methods and results In the fourth Tromsø Study, M‐mode echocardiography was performed in 2504 subjects with available serum 25(OH)D measurements. Measurements of EF and LV mass indexed by height (LVMH) were obtained. Only non‐smoking men ( n = 790) and women ( n = 944) were included in the final analysis. Linear regression was used to assess the association between serum 25(OH)D and measurements of systolic function, and logistic regression was applied to assess the effect of serum 25(OH)D on the lowest quartile of EF (yes/no) and LV hypertrophy (LVH) (yes/no). We found no significant associations between vitamin D concentrations and measures of LV systolic function, when adjusted for other risk factors and the season when 25(OH)D sampling was performed [β –0.03, 95% confidence interval (CI) –0.08 to 0.03, and β –0.01, 95% CI –0.07 to 0.06 for LVMH and EF in men; and β 0.02, 95% CI –0.03 to 0.07, and β 0.01, 95% CI –0.05 to 0.07 for LVMH and EF in women]. Serum 25(OH)D did not predict EF and/or LVH in both genders. Conclusions In our population‐based study, increased serum 25(OH)D was not associated with better LV systolic function, when adjusted for other risk factors and for season of vitamin D sampling. Article in Journal/Newspaper Tromsø Wiley Online Library Tromsø European Journal of Heart Failure 15 5 490 495
institution Open Polar
collection Wiley Online Library
op_collection_id crwiley
language English
description Aims The myocardium is considered to be an important target organ for parathyroid hormone and 1,25‐dihydroxyvitamin D, the active metabolite of vitamin D. Vitamin D inadequacy has also been linked to cardiovascular morbidity. We aimed to evaluate the relationship between serum 25‐hydroxyvitamin D [25(OH)D] and LV systolic function in a general population. Methods and results In the fourth Tromsø Study, M‐mode echocardiography was performed in 2504 subjects with available serum 25(OH)D measurements. Measurements of EF and LV mass indexed by height (LVMH) were obtained. Only non‐smoking men ( n = 790) and women ( n = 944) were included in the final analysis. Linear regression was used to assess the association between serum 25(OH)D and measurements of systolic function, and logistic regression was applied to assess the effect of serum 25(OH)D on the lowest quartile of EF (yes/no) and LV hypertrophy (LVH) (yes/no). We found no significant associations between vitamin D concentrations and measures of LV systolic function, when adjusted for other risk factors and the season when 25(OH)D sampling was performed [β –0.03, 95% confidence interval (CI) –0.08 to 0.03, and β –0.01, 95% CI –0.07 to 0.06 for LVMH and EF in men; and β 0.02, 95% CI –0.03 to 0.07, and β 0.01, 95% CI –0.05 to 0.07 for LVMH and EF in women]. Serum 25(OH)D did not predict EF and/or LVH in both genders. Conclusions In our population‐based study, increased serum 25(OH)D was not associated with better LV systolic function, when adjusted for other risk factors and for season of vitamin D sampling.
format Article in Journal/Newspaper
author Kamycheva, Elena
Wilsgaard, Tom
Schirmer, Henrik
Jorde, Rolf
spellingShingle Kamycheva, Elena
Wilsgaard, Tom
Schirmer, Henrik
Jorde, Rolf
Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study
author_facet Kamycheva, Elena
Wilsgaard, Tom
Schirmer, Henrik
Jorde, Rolf
author_sort Kamycheva, Elena
title Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study
title_short Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study
title_full Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study
title_fullStr Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study
title_full_unstemmed Serum 25‐hydroxyvitamin D and left ventricular systolic function in a non‐smoking population: the Tromsø Study
title_sort serum 25‐hydroxyvitamin d and left ventricular systolic function in a non‐smoking population: the tromsø study
publisher Wiley
publishDate 2013
url http://dx.doi.org/10.1093/eurjhf/hfs210
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1093%2Feurjhf%2Fhfs210
https://onlinelibrary.wiley.com/doi/pdf/10.1093/eurjhf/hfs210
https://onlinelibrary.wiley.com/doi/full-xml/10.1093/eurjhf/hfs210
geographic Tromsø
geographic_facet Tromsø
genre Tromsø
genre_facet Tromsø
op_source European Journal of Heart Failure
volume 15, issue 5, page 490-495
ISSN 1388-9842 1879-0844
op_rights http://onlinelibrary.wiley.com/termsAndConditions#vor
op_doi https://doi.org/10.1093/eurjhf/hfs210
container_title European Journal of Heart Failure
container_volume 15
container_issue 5
container_start_page 490
op_container_end_page 495
_version_ 1800739466985340928